ARCHIVES

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

This article is from The Cancer Letter archive.

Vol. 24 No. 25 | June 26, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978

More Radiation Increases Prostate Cancer Response

August 30, 2002